Valuation : 3SBio Inc.

Market Cap 32.94B 38.48B 4.91B 4.22B 3.98B 3.63B 6.78B 469B 6.84B 47.42B 18.25B 238B 18.43B 18.03B 756B P/E 2026 *
14.1x
P/E 2027 * 13x
Enterprise Value 22.36B 26.12B 3.33B 2.86B 2.7B 2.46B 4.6B 318B 4.65B 32.19B 12.39B 162B 12.51B 12.24B 513B EV / Sales 2026 *
2.38x
EV / Sales 2027 * 1.94x
Free-Float
74.86%
Yield 2026 *
1.55%
Yield 2027 * 1.9%
1 day-0.64%
1 week-5.22%
Current month-4.22%
1 month-14.22%
3 months-6.31%
6 months-29.37%
Current year-36.15%
1 week 15.1
Extreme 15.1
16.63
1 month 15.1
Extreme 15.1
18.65
Current year 14.81
Extreme 14.81
29.3
1 year 14.81
Extreme 14.81
35.42
3 years 4.91
Extreme 4.91
36.8
5 years 4.72
Extreme 4.72
36.8
10 years 4.72
Extreme 4.72
36.8
Manager TitleAgeSince
Chief Executive Officer 63 31/12/2005
Director of Finance/CFO 43 02/07/2023
Corporate Officer/Principal 56 26/11/2014
Director TitleAgeSince
Chairman 63 02/04/2012
Director/Board Member 56 10/06/2012
Director/Board Member 57 31/05/2015
Date Insider Type Main position Quantity % Market Cap. Importance
29/07/25 Other

Chief Executive Officer

440,000 0.0184%
15/04/25 Other

Director

26,000 0.0011%
11/04/25 Other

Director

460,000 0.0192%
Change 5-day change 1-year change 3-year change Capi.($)
-0.64%-5.22%-53.07%+131.14% 4.94B
-1.16%-5.27%+38.00%-5.93% 79.21B
-1.42%-4.24%-18.81%-37.78% 58.22B
+9.06%+1.61%+482.47%+39.78% 54.54B
-2.00%-3.66%-10.49%+27.83% 48.89B
+3.07%-1.28%-0.91%+152.24% 44.72B
+0.10%-2.60%+44.51%-16.93% 31.83B
-0.53%-3.75%+41.57%+89.40% 24.99B
-0.85%-8.82%-6.07%+164.64% 20.95B
+0.30%-3.30%+64.10%+98.29% 15.8B
Average +0.58%-5.06%+58.13%+64.27% 38.41B
Weighted average by Cap. +0.86%-5.14%+80.08%+39.09%

Financials

2026 *2027 *
Net sales 9.38B 10.95B 1.4B 1.2B 1.13B 1.03B 1.93B 134B 1.95B 13.5B 5.2B 67.75B 5.25B 5.13B 215B 10.01B 11.7B 1.49B 1.28B 1.21B 1.1B 2.06B 143B 2.08B 14.42B 5.55B 72.35B 5.6B 5.48B 230B
Net income 2.34B 2.73B 349M 300M 283M 258M 482M 33.33B 486M 3.37B 1.3B 16.91B 1.31B 1.28B 53.7B 2.63B 3.07B 392M 337M 318M 290M 541M 37.46B 546M 3.79B 1.46B 19B 1.47B 1.44B 60.36B
Net Debt -10.58B -12.36B -1.58B -1.36B -1.28B -1.17B -2.18B -151B -2.2B -15.23B -5.86B -76.43B -5.92B -5.79B -243B -13.55B -15.83B -2.02B -1.74B -1.64B -1.49B -2.79B -193B -2.81B -19.51B -7.51B -97.9B -7.58B -7.41B -311B
Logo 3SBio Inc.
3SBio Inc is an investment holding company principally engaged in the development, production, marketing and sale of biopharmaceutical products. The Company's main products include biopharmaceuticals such as TPIAO, EPIAO, Yisaipu, and Cipterbin, as well as small moleculessuch as Mandi and Remitch. The Company is also engaged in the contract development and manufacturing operations (CDMO) business that provides customers with research, development and production of a variety of biopharmaceuticals and therapeutic technology platform services. The Company's products are mainly used for chemotherapy-induced thrombocytopenia (CIT), anemia caused by chronic kidney disease (CKD), treatment of chemotherapy-induced anemia (CIA), ankylosing spondylitis (AS) and psoriasis. The Company mainly operates its businesses in the domestic and overseas markets.
Employees
6,068
Date Price Change Volume
11/09/26 HK$15.44 -0.64% 19,171,711
10/09/26 HK$15.54 -3.78% 35,811,208
09/09/26 HK$16.15 -1.70% 16,834,177
08/09/26 HK$16.43 +2.43% 15,426,469
07/09/26 HK$16.04 -1.23% 9,889,784
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
13.30CNY
Average target price
26.68CNY
Spread / Average Target
+100.57%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 1530 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!